Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood diseases
Biotech
Vertex and Orna team up to develop new blood disorder treatments
Vertex is hoping to build out its inherited blood disease portfolio, teaming up with Orna to develop next-gen gene therapies for SCD and TDT.
Gabrielle Masson
Jan 7, 2025 7:00am
ASH surveys identify barriers to improving diversity in research
Dec 16, 2024 5:10pm
Sanofi BTK inhibitor for blood disease raises platelet levels
Nov 5, 2024 1:42pm
Silence breaks down phase 1 data on blood disorder prospect
Jun 27, 2024 9:40am
Takeda's anti-CD38 antibody boosts platelet count in phase 2
Jun 24, 2024 8:58am
Takeda plays Protagonist, paying $300M for blood disease pact
Jan 31, 2024 5:41pm
